These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26312563)

  • 1. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Loilome W; Yongvanit P; Khuntikeo N; Nielsen PS; Paorojkul C; Takahashi Y; Maekawa Y
    Tumour Biol; 2014 Mar; 35(3):1985-95. PubMed ID: 24122204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.
    Hamada S; Satoh K; Hirota M; Kanno A; Ishida K; Umino J; Ito H; Kikuta K; Kume K; Masamune A; Katayose Y; Unno M; Shimosegawa T
    Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.
    Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P
    Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
    Nakanuma Y; Uchida T; Sato Y; Uesaka K
    Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
    Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
    Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
    Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
    Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of S100 protein expression in cholangiocarcinoma.
    Sato Y; Harada K; Sasaki M; Nakanuma Y
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1422-9. PubMed ID: 23621473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma.
    Haonon O; Rucksaken R; Pinlaor P; Pairojkul C; Chamgramol Y; Intuyod K; Onsurathum S; Khuntikeo N; Pinlaor S
    Proteomics Clin Appl; 2016 Mar; 10(3):248-56. PubMed ID: 26435198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma.
    Jamnongkan W; Techasen A; Thanan R; Duenngai K; Sithithaworn P; Mairiang E; Loilome W; Namwat N; Pairojkul C; Yongvanit P
    Tumour Biol; 2013 Apr; 34(2):695-704. PubMed ID: 23188705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
    Duangkumpha K; Stoll T; Phetcharaburanin J; Yongvanit P; Thanan R; Techasen A; Namwat N; Khuntikeo N; Chamadol N; Roytrakul S; Mulvenna J; Mohamed A; Shah AK; Hill MM; Loilome W
    PLoS One; 2019; 14(8):e0221024. PubMed ID: 31425520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Pinlaor S; Pairojkul C; Chamgramol Y; Takahashi Y
    Tumour Biol; 2012 Aug; 33(4):1169-78. PubMed ID: 22373585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
    Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
    Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.